Literature DB >> 17179171

Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra.

Pedro J Ruiz, Eliezer Masliah, Taylor A Doherty, Ai Quach, Gary S Firestein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17179171      PMCID： PMC1856013          DOI： 10.1136/ard.2006.060541

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH.

Authors:  Stefan D Anker; Andrew J S Coats
Journal:  Int J Cardiol       Date:  2002-12       Impact factor: 4.164

Review 2.  Interleukin-18.

Authors:  C A Dinarello
Journal:  Methods       Date:  1999-09       Impact factor: 3.608

Review 3.  Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications.

Authors:  Stephan von Haehling; Ewa A Jankowska; Stefan D Anker
Journal:  Basic Res Cardiol       Date:  2003-08-21       Impact factor: 17.165

4.  Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism.

Authors:  D Panas; F H Khadour; C Szabó; R Schulz
Journal:  Am J Physiol       Date:  1998-09

5.  Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.

Authors:  Eugene S Chung; Milton Packer; Kim Hung Lo; Adedigbo A Fasanmade; James T Willerson
Journal:  Circulation       Date:  2003-06-09       Impact factor: 29.690
  5 in total
  12 in total

1.  Diabetes treatment--bridging the divide.

Authors:  Kristina I Rother
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

2.  [Adult onset Still's disease].

Authors:  B Manger
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

3.  [Recommendations on therapy using interleukin-1beta-blocking agents].

Authors:  B Manger; M Gaubitz; H Michels
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 4.  Autoinflammation: translating mechanism to therapy.

Authors:  Taylor A Doherty; Susannah D Brydges; Hal M Hoffman
Journal:  J Leukoc Biol       Date:  2011-02-17       Impact factor: 4.962

5.  Anakinra for myocarditis in juvenile idiopathic arthritis.

Authors:  Rajesh Movva; Suzanne B Brown; D Lynn Morris; Vincent M Figueredo
Journal:  Tex Heart Inst J       Date:  2013

Review 6.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

7.  [IL-1 antagonists].

Authors:  I Kötter; G Horneff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

8.  Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation.

Authors:  Matteo Colina; Marcello Govoni; Francesco Trotta
Journal:  Rheumatol Int       Date:  2008-12-02       Impact factor: 2.631

Review 9.  Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.

Authors:  Apostolos Kontzias; Petros Efthimiou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Authors:  Matthew L Stoll; Alisa C Gotte
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.